Sugi Predict

Sugi Predict / Compounds / SCHEMBL5652364

SCHEMBL5652364

SCHEMBL5652364

CC1(c2cccc(C(N)=O)c2)C(=O)N(Cc2ccc3ccc(C=NN)cc3c2)C(=O)N1Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTRB1 P17538 1/20 0.39
▸ OPRM1 P35372 8/20 0.39
▸ OPRK1 P41145 6/20 0.39
▸ OPRD1 P41143 4/20 0.37
▸ PTPN1 P18031 3/20 0.35
▸ ACP1 P24666 3/20 0.35
▸ OPRL1 P41146 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ FNTA P49354 2/20 0.34
▸ FNTB P49356 2/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ AMPD2 Q01433 1/20 0.33
▸ PTPN2 P17706 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5650848 0.97 CTRB1 (0.39) CTRB1OPRM1OPRK1OPRD1PTPN1
SCHEMBL5648228 0.94 PTPN1 (0.40) PTPN1ACP1MEN1HPGDKMT2A
SCHEMBL5648086 0.93 CTRB1 (0.40) CTRB1OPRM1OPRK1PTPN1ACP1
SCHEMBL5645171 0.93 CTRB1 (0.40) CTRB1OPRM1PTPN1ACP1OPRL1
Trifluoroacetic Acid SCHEMBL5649098 0.92 CTRB1 (0.36) CTRB1OPRM1OPRK1OPRD1PTPN1
SCHEMBL5648162 0.91 KMT2A (0.41) PTPN1ACP1KDM4EALDH1A1KMT2A
SCHEMBL5649247 0.89 PTPN1 (0.44) CTRB1PTPN1ACP1MEN1HPGD
SCHEMBL5647820 0.88 PTPN1 (0.44) CTRB1PTPN1ACP1MEN1HPGD
SCHEMBL5650573 0.88 TRPA1 (0.42) OPRM1OPRD1PTPN1KDM4EMEN1
SCHEMBL5645241 0.85 KMT2A (0.36) CTRB1PTPN1ACP1OPRL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7199146-B2 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2007-04-03 — — US disclosed
US-20060142363-A1 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2006-06-29 — — US disclosed
US-7053112-B2 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2006-05-30 — — US disclosed
US-20040122073-A1 Imidazolidinedione analogs useful as anticoagulants and antihrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2004-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122073-A1 Imidazolidinedione analogs useful as anticoagulants and antihrombotics SERPINC1, F2, BDKRB1 CTRB1 259/4885OPRM1 2050/4885OPRK1 1479/4885
US-20060142363-A1 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SERPINC1, F2, BDKRB1 CTRB1 208/4885OPRM1 3580/4885OPRK1 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.